Research Peptides in St. George, UT

Shipping research peptides to St. George

Research groups in St. George receive third-party-tested vials with fast domestic dispatch. Peptides Factory Direct ships the full catalog to St. George and across Utah; material arrives as a refrigerator-stable powder ready for reconstitution, and each St. George lot carries a 99%+ purity target with a COA on request and a tracked lot number.

Research peptide categories shipped to St. George

St. George researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides St. George researchers request most

Below are the research peptides St. George laboratories most often order. Each summary reflects the published research literature and is provided for laboratory context only, and every compound is research-use-only and is not for human or animal consumption.

Thymosin Alpha-1 (immune peptide) research

Thymosin Alpha-1 is a 28-amino-acid peptide originally isolated from the thymus gland. It is a well-studied immune-modulation research peptide with an extensive literature on T-cell signaling.

Research mechanism. Thymosin Alpha-1 research focuses on modulation of T-cell maturation and innate immune signaling, making it a model compound for immune and antiviral research.

Immune-modulation research. The central theme - T-cell and innate-immune signaling models.

Antiviral research. Studied in models of immune response to viral challenge.

Longevity / immune-aging research. Examined in immunosenescence designs.

How it compares. Thymosin Alpha-1 targets immune signaling, distinguishing it from telomere-focused Epithalon and the structural healing peptides.

Research pairings. Sometimes studied alongside Epithalon in immune-and-aging research designs.

Reference research values. Research references commonly cite 0.5-1 mg two to three times weekly. Reference values only.

Full Thymosin Alpha-1 research profile → · Anti-Aging & Longevity peptides

Semax (BDNF nootropic) research

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia. It is studied for cognitive and neuroprotective endpoints and is one of the most-cited nootropic research peptides.

Research mechanism. Semax research focuses on up-regulation of BDNF and nerve-growth-factor signaling and on modulation of monoamine systems, with interest in learning, memory, and neuroprotection endpoints.

Cognitive / focus research. Studied for attention, learning, and memory endpoints.

Neuroprotection research. Examined in models of neural stress and recovery.

BDNF-signaling research. A model compound for neurotrophic-factor studies.

How it compares. Semax is studied more for focus and BDNF, Selank more for anxiety; N-Acetyl Semax Amidate is a more potent, longer-lasting analog.

Research pairings. Semax + Selank pairs focus and anxiety endpoints in cognitive research.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full Semax research profile → · Cognitive & Neurological peptides

Selank (anxiolytic nootropic) research

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia. It is studied for anxiolytic (anti-anxiety) and cognitive endpoints without the sedation associated with classic anxiolytics.

Research mechanism. Selank research focuses on modulation of GABAergic and monoamine signaling and on brain-derived neurotrophic factor (BDNF) expression, with interest in anxiety and focus endpoints.

Anxiolytic research. Studied for anxiety endpoints without sedation in models.

Cognitive / focus research. Examined for attention and mental-clarity variables.

Neuroprotection and immune research. Its tuftsin lineage links it to immune-signaling studies.

How it compares. Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research.

Research pairings. Selank + Semax is a common cognitive-research pairing (anxiety plus focus endpoints).

Reference research values. Research references commonly cite 250-500 mcg daily across 2-4 week cycles. Reference values only.

Full Selank research profile → · Cognitive & Neurological peptides

Melanotan II (MT-II) research

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone, a non-selective melanocortin agonist. It is studied for melanogenesis (pigmentation) and broader melanocortin endpoints in research models.

Research mechanism. Melanotan II activates multiple melanocortin receptors, driving melanin production in research models and engaging MC4R pathways relevant to appetite and libido endpoints.

Pigmentation research. Studied for melanogenesis and tanning endpoints in models.

Melanocortin-pathway research. A broad melanocortin agonist for receptor studies.

Appetite/libido signaling research. Examined for MC4R-mediated endpoints.

How it compares. Melanotan II is a non-selective agonist studied for pigmentation and broad melanocortin endpoints; Melanotan I (afamelanotide) is more selective; PT-141 is studied for sexual function.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 0.5-1 mg two to three times weekly. Reference values only.

Full Melanotan II research profile → · Sexual Health & Tanning peptides

TB-500 (Thymosin Beta-4 fragment) research

TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein involved in actin regulation and cell migration. In research it is valued for its reported ability to travel systemically and reach tissue throughout the body rather than acting only at a local site.

Research mechanism. TB-500 research focuses on its binding to G-actin and its role in cell migration, blood-vessel formation, and the recruitment of repair cells to damaged tissue. By promoting cell motility, it is studied as a driver of slower but deeper regeneration than localized repair peptides.

Deep tissue and muscle recovery research. TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.

Chronic-injury models. Its systemic profile makes it common in chronic and hard-to-reach injury models where a localized peptide would be impractical.

Stacked regeneration studies. It is the standard research partner for BPC-157 in connective-tissue regeneration protocols.

How it compares. Where BPC-157 is studied as fast and local, TB-500 is studied as slower and systemic. Researchers often choose between them based on whether whole-body distribution or site-specific action is the variable of interest.

Research pairings. TB-500 + BPC-157 is the most-studied healing pair in the literature; the two are reported to address complementary repair pathways. TB-500 is banned by WADA, a relevant note for sports-science researchers.

Reference research values. Published research references commonly cite a loading phase of 5-10 mg per week split across 2-3 administrations for 4-6 weeks, followed by a 2-5 mg per week maintenance figure. These are reference values from the literature and are not instructions for any living subject.

Full TB-500 research profile → · Healing & Recovery peptides

Dihexa (high-potency nootropic) research

Dihexa is a synthetic peptide derived from angiotensin IV, studied for its reported high potency in promoting synaptic connections (synaptogenesis). The literature describes it as extremely potent relative to BDNF in model systems, with limited human data.

Research mechanism. Dihexa research focuses on the hepatocyte-growth-factor / c-Met system and synaptogenesis, with interest in memory and cognition endpoints.

Synaptogenesis research. Studied for formation of new synaptic connections in models.

Memory and cognition research. Examined for learning and memory endpoints.

Neurodegeneration models. Used in exploratory neurodegeneration research.

How it compares. Dihexa is studied as far more potent than Semax/Selank in model systems but with much less data, making it a specialized research tool.

Research pairings. Generally studied as a standalone high-potency nootropic.

Reference research values. Research references commonly cite 5-10 mg daily in 4-8 week cycled windows. Reference values only - an advanced compound with limited data; use caution.

Full Dihexa research profile → · Cognitive & Neurological peptides

DSIP (Delta Sleep-Inducing Peptide) research

DSIP (delta sleep-inducing peptide) is a naturally occurring neuropeptide studied for its reported association with delta-wave sleep and stress regulation. The research literature is mixed, which makes it an active area of investigation.

Research mechanism. DSIP research examines its role in sleep architecture, stress-hormone modulation, and pain endpoints, though the exact mechanism remains a research question.

Sleep research. Studied for sleep-quality and delta-wave endpoints in models.

Stress-regulation research. Examined for stress-hormone modulation.

Pain-modulation research. Used in exploratory pain-endpoint designs.

How it compares. DSIP is studied specifically for sleep and stress endpoints, distinct from the hormone and cognitive peptides.

Research pairings. Generally studied as a standalone sleep-research peptide.

Reference research values. Research references commonly cite 100-300 mcg before rest periods, used as-needed. Reference values only.

Full DSIP research profile → · Specialty peptides

Gonadorelin (GnRH) research

Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH). It is studied for its role in stimulating the pituitary to release luteinizing hormone and follicle-stimulating hormone in a pulsatile pattern.

Research mechanism. Gonadorelin research focuses on pulsatile GnRH-receptor activation - the natural rhythm matters, so frequent administration is modeled to mimic endogenous pulses.

Reproductive-hormone research. Studied for LH/FSH stimulation endpoints.

Pulsatile-signaling research. Examined for the importance of pulse frequency in models.

Hormone-axis maintenance research. Studied in models of endogenous hormone production.

How it compares. Gonadorelin is GnRH itself; Kisspeptin acts upstream of it, and HCG mimics LH downstream - three distinct points in the hormone axis.

Research pairings. Generally studied as a standalone GnRH peptide.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily in pulsatile designs. Reference values only.

Full Gonadorelin research profile → · Specialty peptides

GHRP-6 (Growth Hormone Releasing Peptide-6) research

GHRP-6 is a hexapeptide and one of the original growth-hormone-releasing peptides. In research it is notable for a strong reported effect on appetite signaling (via ghrelin-receptor activity) in addition to GH release.

Research mechanism. GHRP-6 activates the GH-secretagogue receptor to drive GH pulses and is studied for its pronounced hunger-signaling response, a useful variable in appetite-and-metabolism research.

GH-release research. A potent classic GHRP for growth-hormone-pulse studies.

Appetite-signaling research. Studied where the ghrelin/hunger axis is the variable of interest.

Recovery and tissue models. Examined for downstream recovery endpoints.

How it compares. Compared with Ipamorelin it produces stronger appetite signaling and GH release but with more off-target hormonal activity; GHRP-2 sits between the two.

Research pairings. GHRP-6 is sometimes studied with a GHRH analog like CJC-1295; researchers monitor prolactin in models.

Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.

Full GHRP-6 research profile → · Growth Hormone & Muscle peptides

PT-141 (Bremelanotide) research

PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. It is studied for sexual-function endpoints through a central-nervous-system mechanism rather than a vascular one.

Research mechanism. PT-141 research focuses on activation of melanocortin receptors (notably MC4R) in the central nervous system, which is the distinguishing feature versus vascular mechanisms studied for other compounds.

Libido / sexual-function research. Studied for arousal endpoints in both male and female models via CNS signaling.

Melanocortin-pathway research. A model compound for MC4R signaling studies.

Centrally-mediated research. Used where a central rather than vascular mechanism is the variable.

How it compares. Unlike vascular-pathway compounds, PT-141 acts centrally; unlike Melanotan I/II it is studied primarily for sexual-function rather than tanning endpoints.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 1-2 mg administered 45-90 minutes before the modeled endpoint, used as-needed rather than daily. Reference values only.

Full PT-141 research profile → · Sexual Health & Tanning peptides

Semaglutide (GLP-1 agonist) research

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a long half-life. It is among the most-studied metabolic research peptides because of the extensive GLP-1 literature on glucose handling and satiety signaling.

Research mechanism. Semaglutide research centers on GLP-1-receptor activation: enhanced glucose-dependent insulin signaling, slowed gastric emptying, and central satiety pathways. These endpoints are studied in metabolic and weight-related research models.

Weight-management research. The dominant research theme is appetite and body-weight modeling via GLP-1 signaling.

Glucose-metabolism research. Studied for glucose-dependent insulin and metabolic endpoints.

Comparative GLP-1 studies. Frequently compared with Tirzepatide in dual-pathway research.

How it compares. Semaglutide is a single-pathway GLP-1 agonist; Tirzepatide is a dual GLP-1/GIP agonist. The two are the central comparison in modern metabolic-peptide research.

Research pairings. In research it is studied as a standalone GLP-1 model or compared head-to-head with Tirzepatide.

Reference research values. Research references describe a titration model from 0.25 mg up to 2.4 mg weekly over several weeks. Reference values only.

Full Semaglutide research profile → · Fat Loss & Weight Management peptides

KPV (Lysine-Proline-Valine) research

KPV is the C-terminal tripeptide (lysine-proline-valine) of the alpha-melanocyte-stimulating hormone. In research it is studied because it retains anti-inflammatory activity associated with the parent hormone without the pigmentation effects, making it a clean model compound for inflammation studies.

Research mechanism. KPV research focuses on its reported ability to enter cells and modulate inflammatory transcription pathways (such as NF-kB signaling), reducing pro-inflammatory cytokine output in models of gut and tissue inflammation.

Gut inflammation models. KPV is studied in models relevant to inflammatory bowel research (such as colitis and Crohn-type models) where epithelial inflammation is the variable.

General anti-inflammatory research. It is used as a model peptide for systemic and tissue inflammation studies with minimal off-target signaling.

Immune-modulation research. Its melanocortin lineage makes it relevant to immune-signaling investigations.

How it compares. Unlike BPC-157 and TB-500, which are studied for structural tissue repair, KPV is studied specifically for inflammatory signaling, making it complementary rather than competitive.

Research pairings. In healing research KPV is sometimes studied alongside BPC-157 for combined repair-and-inflammation models.

Reference research values. Research references commonly cite 500-1,000 mcg daily across a 4-12 week study window. Reference values only - not dosing for any subject.

Full KPV research profile → · Healing & Recovery peptides

HCG (Human Chorionic Gonadotropin) research

HCG (human chorionic gonadotropin) is a glycoprotein hormone that mimics luteinizing hormone. It has a well-established research profile and is studied for its downstream effects on gonadal hormone production.

Research mechanism. HCG research focuses on LH-receptor activation, stimulating gonadal tissue in research models - the downstream counterpart to upstream GnRH and Kisspeptin signaling.

Reproductive-hormone research. Studied for gonadal-hormone and fertility endpoints.

LH-analog research. A model compound for LH-receptor studies.

Hormone-axis research. Examined in models of endogenous hormone support.

How it compares. HCG mimics LH downstream, while Gonadorelin and Kisspeptin act upstream in the same axis.

Research pairings. Studied alongside GnRH peptides in hormone-axis research designs. Banned by WADA - relevant for sports-science researchers.

Reference research values. Research references commonly cite 250-500 IU two to three times weekly. Reference values only.

Full HCG research profile → · Specialty peptides

AOD 9604 (HGH Fragment 176-191) research

AOD 9604 is a modified fragment (residues 176-191) of human growth hormone, representing the region associated with fat metabolism. It is studied because it isolates the lipolytic portion of GH without the growth-signaling or glucose effects of the whole hormone.

Research mechanism. AOD 9604 research focuses on stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis without acting on the IGF-1 axis or blood glucose - the defining research feature.

Lipolysis research. Studied specifically for fat-metabolism endpoints in models.

Metabolic models without glucose effect. Useful where researchers want fat signaling isolated from blood-sugar variables.

Stubborn-fat research. Examined in models of resistant adipose tissue.

How it compares. Unlike GLP-1 peptides that act on appetite, AOD 9604 isolates the fat-metabolism portion of GH and does not affect blood sugar - a distinct research mechanism.

Research pairings. Sometimes studied alongside GH-secretagogues in metabolic research designs.

Reference research values. Research references commonly cite 300-600 mcg daily (often modeled in a fasted window) over 12-16 week study periods. Reference values only.

Full AOD 9604 research profile → · Fat Loss & Weight Management peptides

Research applications studied in St. George

• Immune-modulation research (Thymosin Alpha-1). The central theme - T-cell and innate-immune signaling models.
• Cognitive / focus research (Semax). Studied for attention, learning, and memory endpoints.
• Anxiolytic research (Selank). Studied for anxiety endpoints without sedation in models.
• Pigmentation research (Melanotan II). Studied for melanogenesis and tanning endpoints in models.
• Deep tissue and muscle recovery research (TB-500). TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.

How St. George researchers order and store material

Ordering for a St. George lab is done in the Peptides Factory Direct portal, with one-time or recurring options and a checkout confirmation of laboratory research use. Material ships to St. George as a lyophilized powder for refrigerated storage; after reconstitution keep it cold and use within the standard research window. St. George researchers remain responsible for compliance with applicable law, and nothing supplied is for human or animal consumption. Open the order portal.

Why St. George researchers choose Peptides Factory Direct

Serious research material is judged on verifiable purity, not marketing. Peptides Factory Direct ships every St. George order with a 99%+ purity target, a Certificate of Analysis on request, lot tracking, and reference research documentation for every compound in the catalog. Fast domestic dispatch means St. George labs receive stable vials quickly.

Nearby Utah research areas we ship to

Frequently asked questions

All Utah cities · All states · Research guides

External references: Utah (Wikipedia) · U.S. Census Bureau